Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

1(20.0%)

Phase 2

1(20.0%)

5Total

N/A(3)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03467776Suspended

Bronchial Dilation Test in Wheezy Infants

Role: collaborator

NCT02504528Not ApplicableCompleted

Bronchial Allergen Provocation Tests in Asthmatics in Guangzhou

Role: collaborator

NCT02502825Not ApplicableCompleted

Comparison of Methacholine Bronchial Provocation With Wright and Devilbiss646 Nebulizers

Role: collaborator

NCT00526357Phase 2Completed

Effect of Dietary Supplements With Fish Oil on Mannitol-induced Airway Sensitivity & Inflammation in Persons With Asthma

Role: lead

NCT00196547Phase 4Completed

Montelukast in Modulating Exacerbations of Asthma in Children

Role: lead

NCT00229190Not ApplicableCompleted

Nasal Lavage Study: Comparing Single Versus Multi Sample Lavages

Role: collaborator

All 6 trials loaded